www.naceonline.com Open in urlscan Pro
52.6.19.39  Public Scan

Form analysis
0 forms found in the DOM

Text Content

You need to enable javascript to view this website.
You are currently acting as a learner. Return to Management
 * Sign In
   
   
 * Cart (0)
   
   


 * 
 * Menu

   
   
 * Topics
   
   
 * Live Courses
   
   
 * On Demand Courses
   
   
 * About NACE
   
   
 * Learner Dashboard
   
   
 * Podcasts
   
   
 * Sponsored Opportunities
   
   
 * Need a Site Tutorial?
   
   
 * Register


COMING OUT OF THE DARK: ADVANCES IN MIGRAINE CARE


   
   
 * Description
   
   

Summary

Recent advances in the understanding and treatment of migraine offer the
opportunity to individualize the care of patients with this disorder. Multiple
new treatment options are available, which marks a new era in migraine
management. A number of anti-calcitonin gene-related peptide (CGRP) monoclonal
antibodies have been approved for migraine prevention, small molecule CGRP
receptor antagonists (gepants) have been approved for acute care and prevention,
and a 5-hydroxytryptamine-1F (5-HT1F) receptor agonist (ditan) has been approved
for acute care treatment. This course will address diagnosis, treatment, and
clinician-patient communication strategies to optimize patient care.

Learning Objectives

At the conclusion of this activity, the learner will be able to:

 * Individualize the use of acute care therapies to manage migraine, based on
   mechanisms of action, efficacy data, patient preferences, and tolerability
 * Utilize CGRP therapies to prevent migraine in appropriate patients, based on
   mechanisms of action, efficacy data, patient preferences, and tolerability

Course Director
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Faculty
Alan M. Rapoport, MD
Clinical Professor of Neurology
The David Geffen School of Medicine at UCLA
Los Angeles, CA
Past President
The International Headache Society (IHS)
Founder and Director-Emeritus
The New England Center for Headache
Stamford, CT

Peer Reviewer
David M. Kaufman, MD
Professor, The Saul R. Korey
Department of Neurology
Professor, Department of Psychiatry and Behavioral Sciences
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

CME Reviewer
Victor B. Hatcher, PhD
Associate Dean, Continuing Professional Development
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

NACE Staff and Planning Committee
Sandy Bihlmeyer, MEd
Senior Project Manager
National Association for Continuing Education
Plantation, FL

Michelle Frisch, MPH
Vice President, Operations
National Association for Continuing Education
Plantation, FL

Angela Golden, DNP, FNP-C, FAANP
Family Nurse Practitioner
NP Obesity Treatment Clinic and NP from Home, LLC
Assistant Professor (Ret), Northern Arizona University
Past President, American Association of Nurse Practitioners
Munds Park, AZ

Peter Hanna, PharmD
Assistant Scientific Director
National Association for Continuing Education
Plantation, FL

Daniela Hiedra
Program Manager, Grant Accounts and Events
National Association for Continuing Education
Plantation, FL

Joshua F. Kilbridge  
President and Creative Director 
Kilbridge Associates
San Francisco, CA 

Sheila Lucas, CWEP
Program Manager, Grant Accounts and Events
National Association for Continuing Education
Plantation, FL 

Mayra Orlando
Activity Director
National Association for Continuing Education
Plantation, FL 

Simon Schrick-Senasac, DO, MS
Assistant Scientific Director
National Association for Continuing Education
Plantation, FL

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Conflict of Interest Disclosure Statement

The “Policy on Identification, Mitigation and Disclosure of Relevant Financial
Relationships” of Albert Einstein College of Medicine-Montefiore Medical Center
(Einstein-Montefiore) requires that faculty, and all individuals in a position
to control the educational content of an accredited activity, disclose all
financial relationships with ineligible companies* within the 24 months prior to
their involvement in the activity. Einstein-Montefiore resolves all conflicts of
interest to ensure independence, objectivity, balance, and scientific rigor in
all its educational activities. All relevant financial relationships and
potential conflicts of interest are mitigated prior to the activity. Any faculty
or individual whose disclosed relationships prove to create a conflict of
interest, with regard to their contribution to the activity, will not be
permitted to present.

*The ACCME defines an ineligible company as those whose primary business is
producing, marketing, re-selling or distributing healthcare products used by or
on patients.

Credit Designation Statement

Albert Einstein College of Medicine-Montefiore Medical Center designates this
live activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians
should claim only the credit commensurate with the extent of their participation
in the activity.

Accreditation Statement– CME Provider

In support of improving patient care, Albert Einstein College of
Medicine-Montefiore Medical Center is jointly accredited by the Accreditation
Council for Continuing Medical Education (ACCME), the Accreditation Council for
Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC),
to provide continuing education for the healthcare team.






Accreditation Statement – AANP Provider

National Association for Continuing Education is accredited by the American
Association of Nurse Practitioners as an approved provider of nurse practitioner
continuing education. Provider number: 121222. This activity is approved for 0.5
Contact hours (which includes 0.5 hours of pharmacology).





For additional information about the accreditation of this program, please
contact NACE at info@naceonline.com


How to claim credit


 1. Review the curriculum front matter
 2. Participate in the curriculum
 3. Complete the post-test and activity evaluation
 4. You must score 70% or higher on the post-test to receive credit for this
    activity

Policy on Faculty and Provider Disclosure

Educational programs sponsored by the National Association for Continuing
Education (NACE) must demonstrate balance, independence, objectivity, and
scientific rigor. All faculty, authors, editors, staff and planning committee
members participating in a NACE-sponsored activity are required to disclose any
relevant financial interest or other relationship with the manufacturer(s) of
any commercial product(s) and/or provider(s) of commercial services that are
discussed in an educational activity. Any potential conflicts of interest will
be resolved prior to the activity.

Per the ACCME, a Commercial Interest is defined as an entity producing,
marketing, re-selling or distributing health care goods or services consumed by
or used on, patients. Providers of clinical service directly to patients are not
considered to be commercial interests - unless the provider of the clinical
service is owned, or controlled by, a defined commercial interest.


Individual Disclosure Statements

Sandy Bihlmeyer has no relevant financial relationship with an ACCME-defined
ineligible company in the past 24 months.


Michelle Frisch has no relevant financial relationship with an ACCME-defined
ineligible company in the past 24 months.

Angela Golden has no relevant financial relationship with an ACCME-defined
ineligible company in the past 24 months.

Peter Hanna has no relevant financial relationship with an ACCME-defined
ineligible company in the past 24 months.

Victor B. Hatcher has no relevant financial relationship with an ACCME-defined
ineligible company in the past 24 months.

Daniela Hiedra has no relevant financial relationship with an ACCME-defined
ineligible company in the past 24 months.

David Kaufman has no relevant financial relationship with an ACCME-defined
ineligible company in the past 24 months.

Joshua F. Kilbridge has no relevant financial relationship with an ACCME-defined
ineligible company in the past 24 months.

Sheila Lucas has no relevant financial relationship with an ACCME-defined
ineligible company in the past 24 months.

Mayra Orlando has no relevant financial relationship with an ACCME-defined
ineligible company in the past 24 months.

Alan M. Rapoport has disclosed the following financial relationships:

 * Consultant: AbbVie, Amgen, Biohaven Pharmaceuticals, Cala Health, Satsuma
   Pharmaceuticals, Teva Pharmaceutical
 * Speaker: AbbVie, Amgen, Biohaven Pharmaceuticals, Lundbeck and Teva
   Pharmaceutical

Dr. Rapoport has indicated that his financial relationships will not impact his
ability to discuss material that is balanced, non-biased, accurate, current and
scientifically rigorous.

All relevant financial relationships and potential conflicts of interest have
been mitigated.

Simon Schrick-Senasac has no relevant financial relationship with an
ACCME-defined ineligible company in the past 24 months.

Gregg Sherman has no relevant financial relationship with an ACCME-defined
ineligible company in the past 24 months.

Faculty, and planners for this educational activity below not listed in the
Faculty and Planning Committee Disclosures above have no relevant financial
relationship(s) to disclose with ineligible companies whose primary business is
producing, marketing, selling, re-selling, or distributing healthcare products
used by or on patients.

Disclosure of Unlabeled/Investigational Uses of Products


Albert Einstein College of Medicine-Montefiore Medical Center requires that
faculty participating in any CME/CE activity disclose to the audience when
discussing any unlabeled or investigational use of any commercial product or
device, not yet approved in the United States.

Commercial Support Statement

This activity is supported by educational funding provided by Amgen and
educational funding provided by Biohaven Pharmaceuticals.

Course Summary

Cost: Free

Start Date: 6/15/2022

Expiration Date: 6/14/2023

Target Audience: Primary care physicians, nurse practitioners, physician
assistants, and other clinicians managing patients with migraine.

Format: Interactive Monograph


Estimated Time To Complete CME Activity: 0.5 hour

Credits:
0.5 AMA PRA Category 1 CreditTM
0.5 AANP Contact hour which includes 0.5 pharmacology hour

Hardware/Software Requirements: Any web browser

ENROLL TODAY

Course Runs: Jun 15th 2022 – Jun 14th 2023

Register now to gain access to this course.

Register Now
Already Registered? Sign In

Register Now
© 2022 National Association for Continuing Education, LLC Powered By Thought
Industries
 * 
 * 

 * Home
 * About Us
 * Catalog
 * Outcomes Publications

The National Association for Continuing Education is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to provide
continuing medical education for physicians.

National Association for Continuing Education is accredited by the American
Association of Nurse Practitioners as an approved provider of nurse practitioner
continuing education. Provider number: 121222.

This material may not be published, broadcast, rewritten or redistributed in any
form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy
Policy and Terms & Conditions.

--------------------------------------------------------------------------------


OTHER HAYMARKET CONTINUING MEDICAL EDUCATION WEBSITE



--------------------------------------------------------------------------------

NACE  |  300 Northwest 70 th Avenue, Suite 102  |  Plantation, Florida 33317    
Toll Free: (866) 266-6223  |  Phone: (954) 723-0057  |  E-mail:
info@naceonline.com

We use necessary cookies to make our site work. By clicking 'accept', you agree
that we may also set optional analytics and third party behavioral advertising
cookies to help us improve our site and to provide information to third parties.
For more information on how these cookies work, please see our privacy policy.
Accept